Home  ›  Genabio  ›  Genabio COVID-19 Rapid Self-Test Kit

Genabio COVID-19 Rapid Self-Test Kit

Regular price $4.98
Sale price $4.98 Regular price $9.96
Unit price
$4.98/box
Save 50%
In Stock
Rendering loop-subscriptions
Fast and accurate at-home testing.
  • Exp. Date: 02-2026
  • NDC# 60008095486
  • FDA Authorized
  • HSA/FSA Eligible
  • Non-Invasive Testing
  • 1 test per box
Choose your purchase type:

Subscription Details:

  • Save 10-15% on all subscription orders!
  • Cancel anytime from your customer portal.
  • Super flexible subscription controls.
  • SMS/email notifications on upcoming orders.
  • Choose your delivery schedule:
Pickup available at PHARMALYNK WAREHOUSE

Usually ready in 4 hours

  • Save up to 30% with HSA | FSA funds.

    Shop all
  • All orders ship the same day (Free $250+)

  • Save 10% — on auto-renew orders.

  • Wholesale Program available

Ensure your safety and the well-being of your loved ones with the Genabio COVID-19 Rapid Self-Test Kit. Designed for fast and accurate at-home testing, this FDA-authorized kit provides reliable results in just 15 minutes. The non-invasive short nasal swab ensures a comfortable testing experience, making it ideal for anyone in your household. With eligibility for HSA/FSA reimbursement, this test is both accessible and affordable, trusted by healthcare professionals nationwide. The Genabio COVID-19 Rapid Self-Test Kit is a lateral flow chromatographic immunoassay method intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nasal swab specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19.

A global leader in at-home self-testing products.

Genabio Diagnostics Inc. is a global leader in at-home self-testing products, offering a comprehensive portfolio that includes infectious disease tests, women's health self-tests, rapid drug abuse tests, and metabolic health monitoring products. At Genabio Diagnostics Inc., our success in the in vitro diagnostic market is driven by cutting-edge technology, deep market expertise, and a robust network of collaborations. Looking ahead, we remain committed to innovation and excellence, with the goal of leading the global in vitro diagnostics sector. Our mission is to enhance global health awareness and accessibility through cost-efficient, high-quality self-testing products. We strive to lead in innovation, expand our impact, and empower individuals worldwide to conveniently and accurately monitor their health.

FAQs

The test is highly accurate and has been authorized by the FDA for emergency use. It is trusted by healthcare professionals nationwide.

You will receive your results in just 15 minutes after administering the test.

Yes, the test uses a gentle short nasal swab, designed for a comfortable and non-invasive experience.

Yes, the Genabio COVID-19 Rapid Self-Test Kit is eligible for HSA/FSA reimbursement.

Each package includes 1 test.

About Genabio
Science meets self-care.
Genabio Diagnostics Inc. is a global leader in at-home self-testing products, offering an extensive portfolio that includes infectious disease tests, women's health self-tests, men's infertility rapid tests, drug abuse rapid tests, and metabolic health monitoring products.